Results 221 to 230 of about 102,570 (330)

ANAPHYLAXIS IN ITS RELATION TO PEDIATRICS [PDF]

open access: green, 1911
GODFREY R. PISEK
openalex   +1 more source

Safety and Tolerability of a 3‐h Build‐Up Phase With Hymenoptera Venom Depot Extracts: Preliminary Results

open access: yes
Allergy, EarlyView.
Alessandro Buonomo   +6 more
wiley   +1 more source

Dupilumab Efficacy and Safety in Patients With Persistent Asthma: Asia–Pacific Region

open access: yesClinical &Experimental Allergy, EarlyView.
Asthma prevalence is increasing in the Asia–Pacific region, and this population is frequently underrepresented in phase 3 clinical studies. We demonstrate Dupilumab's efficacy and safety among patients with uncontrolled moderate‐to‐severe type 2 asthma.
Qingling Zhang   +13 more
wiley   +1 more source

Perioperative Anaphylaxis: A Systematic Approach to Evaluate High-Risk Drug Allergy. [PDF]

open access: yesCase Rep Crit Care
Navard-Keck A   +4 more
europepmc   +1 more source

Early Origins of Asthma and Allergies: Clues From Studies in China

open access: yesClinical &Experimental Allergy, EarlyView.
The environment we live in harbours both risk and protective factors for asthma and allergies. This is particularly relevant in China, where unique environmental and cultural factors shape disease development. The interplay between these environmental factors, airway immunity, and gut microbiome shapes the susceptibility to asthma and allergies ...
Yike Wang   +5 more
wiley   +1 more source

Mushroom allergy and anaphylaxis. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Özdemir Ö.
europepmc   +1 more source

Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy (BRIT)

open access: yesClinical &Experimental Allergy, EarlyView.
The BRIT registry highlights disparities in access to allergy treatments in the UK, with socio‐economic and ethnic factors affecting care availability. ABSTRACT Background There is an unmet need for specialist allergy treatment in the United Kingdom. Allergen immunotherapy and treatment with omalizumab for chronic spontaneous urticaria (CSU) are key ...
Mich Erlewyn‐Lajeunesse   +60 more
wiley   +1 more source

Home - About - Disclaimer - Privacy